Medidata Solutions, Inc. (NASDAQ:MDSO) reported Q2 2017 earnings this Morning, coming in at $0.31 per share, beating Wall Street’s estimates of $0.28 per Share. Revenue for the quarter came in at $137.41 million beating analyst estimates of $134.28 million
Analyst Coverage For Medidata Solutions, Inc. (NASDAQ:MDSO)
These are 2 Hold Ratings, 9 Buy Ratings .
The current consensus rating for Medidata Solutions, Inc. (NASDAQ:MDSO) is Buy (Score: 2.82) with a consensus target price of $74.80 , a potential (7.65% downside)Recent Insider Trading for Medidata Solutions, Inc. (NASDAQ:MDSO)
- On 6/5/2017 Robert Taylor, Director, sold 5,639 with an average share price of $73.46 per share and the total transaction amounting to $414,240.94.
- On 5/15/2017 Michael L Capone, COO, sold 5,000 with an average share price of $69.46 per share and the total transaction amounting to $347,300.00.
- On 5/1/2017 Michael I Otner, EVP, sold 7,500 with an average share price of $66.39 per share and the total transaction amounting to $497,925.00.
- On 4/4/2017 Tarek Sherif, CEO, sold 2,964 with an average share price of $57.08 per share and the total transaction amounting to $169,185.12.
- On 3/9/2017 Vries Glen Michael De, President, sold 7,500 with an average share price of $56.05 per share and the total transaction amounting to $420,375.00.
- On 3/2/2017 Tarek Sherif, CEO, sold 7,500 with an average share price of $57.06 per share and the total transaction amounting to $427,950.00.
Recent Trading for Medidata Solutions, Inc. (NASDAQ:MDSO) Shares of Medidata Solutions, Inc. closed the previous trading session at 84.88 up +3.88 4.79% with 783,037 shares trading hands.